Long-term Debt and Lease Obligation in USD of Aquestive Therapeutics, Inc. from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term debt and lease obligation, classified as noncurrent.
Summary
Aquestive Therapeutics, Inc. quarterly Long-term Debt and Lease Obligation history and change rate from Q4 2022 to Q4 2024.
  • Aquestive Therapeutics, Inc. Long-term Debt and Lease Obligation for the quarter ending 31 Dec 2024 was $32,500,000, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Long-term Debt and Lease Obligation, Quarterly (USD)
Long-term Debt and Lease Obligation, YoY Quarterly Change (%)

Aquestive Therapeutics, Inc. Quarterly Long-term Debt and Lease Obligation (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $32,500,000 +$4,992,000 +18% 31 Dec 2024 10-K 05 Mar 2025 2024 FY
Q4 2023 $27,508,000 -$5,940,000 -18% 31 Dec 2023 10-K 05 Mar 2025 2024 FY
Q4 2022 $33,448,000 31 Dec 2022 10-K 05 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.